Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thoma Cressey Partners was a prominent private equity firm that specialized in the 'buy-and-build' investment strategy across various industries, with a core focus on healthcare and life sciences. Founded by industry veterans Carl Thoma and Bryan Cressey, the firm was instrumental in consolidating fragmented markets by acquiring platform companies and scaling them through aggressive add-on acquisitions. The firm's healthcare portfolio spanned services, medical products, and specialty pharmaceuticals, making it a key player in the evolution of the healthcare investment landscape. In 2008, the firm underwent a strategic split to allow its partners to focus on specific sectors, leading to the creation of Thoma Bravo for software and Cressey & Company for healthcare. Today, the legacy of Thoma Cressey Partners continues through these successor firms, which remain leaders in their respective fields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thoma Cressey Partners.